tarextumab

Biotech Movers: OncoMed, Incyte, Omeros
TheStreet.com
Mon, 04/17/17 - 11:22 am
biotech
OncoMed
tarextumab
small cell lung cancer
Incyte
Eli Lilly
baricitinib
Omeros
OncoMed stock plunges after negative findings by study monitoring board
Marketwatch
Mon, 01/25/16 - 09:53 am
OncoMed
tarextumab
GSK
clinical trials
OncoMed initiates Phase 2 ALPINE trial of tarextumab
Yahoo/Fly on the Wall
Wed, 07/16/14 - 10:38 am
OncoMed
tarextumab
pancreatic cancer
Abraxane